(Q118251728)

English

Elucidating Mechanisms for Drug Combination Nanoparticles to Enhance and Prolong Lymphatic Exposure: Experimental and Modeling Approaches

doctoral thesis by John Cavin Kraft II, 2018

In more languages

default for all languages

No label defined

No description defined

edit

Statements

1 reference

1 reference

2018

1 reference

OCLC control number

1078223661

title

Elucidating Mechanisms for Drug Combination Nanoparticles to Enhance and Prolong Lymphatic Exposure (English)

1 reference

OCLC control number

1078223661

subtitle

Experimental and Modeling Approaches (English)

1 reference

1 reference

University of Washington

dissertation program

University of Washington Department of Pharmaceutics

1 reference

OCLC control number

1078223661

language of work or name

1 reference

31 January 2023

full work available at URL

http://hdl.handle.net/1773/42508

0 references

on focus list of Wikimedia project

WikiProject PCC Wikidata Pilot/University of Washington

0 references

thesis committee member

Rodney J Y Ho

object of statement has role

chairperson

1 reference

OCLC control number

1078223661

Identifiers

0 references

0 references

(Q118251728)

Elucidating Mechanisms for Drug Combination Nanoparticles to Enhance and Prolong Lymphatic Exposure: Experimental and Modeling Approaches

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)